1. Home
  2. ONEW vs ZURA Comparison

ONEW vs ZURA Comparison

Compare ONEW & ZURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OneWater Marine Inc.

ONEW

OneWater Marine Inc.

N/A

Current Price

$9.62

Market Cap

211.7M

ML Signal

N/A

Logo Zura Bio Limited

ZURA

Zura Bio Limited

N/A

Current Price

$4.57

Market Cap

455.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ONEW
ZURA
Founded
2014
2022
Country
United States
United States
Employees
N/A
N/A
Industry
Auto & Home Supply Stores
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
211.7M
455.4M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
ONEW
ZURA
Price
$9.62
$4.57
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$16.50
$13.00
AVG Volume (30 Days)
76.3K
1.7M
Earning Date
04-30-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
2.77
N/A
Revenue
$1,872,334,000.00
N/A
Revenue This Year
$0.30
N/A
Revenue Next Year
$3.14
N/A
P/E Ratio
$3.69
N/A
Revenue Growth
5.62
N/A
52 Week Low
$8.12
$1.88
52 Week High
$17.35
$7.25

Technical Indicators

Market Signals
Indicator
ONEW
ZURA
Relative Strength Index (RSI) 30.51 35.03
Support Level $8.99 $4.36
Resistance Level $9.83 $5.87
Average True Range (ATR) 0.70 0.36
MACD -0.24 -0.13
Stochastic Oscillator 5.85 6.58

Price Performance

Historical Comparison
ONEW
ZURA

About ONEW OneWater Marine Inc.

OneWater Marine Inc is a recreational marine retailer in the United States. The company operates in two segments: Dealership and Distribution. The Dealership segment is involved in selling new and pre-owned boats. It also arranges financing and insurance products, provides repairs and maintenance services, offers marine-related parts and accessories, and supplies slip and storage accommodations at certain locations. The Distribution segment focuses on the manufacturing, assembly, and distribution of marine-related products. These products are supplied to distributors, box retailers, and online retailers through a network of warehouses and distribution centers. The company generates the majority of its revenue from the Dealership segment.

About ZURA Zura Bio Limited

Zura Bio Ltd is a clinical-stage biotechnology company developing novel medicines for patients with autoimmune and inflammatory diseases, including serious and debilitating conditions with unmet medical need. These diseases are often chronic, biologically complex, and difficult to treat, and many patients do not achieve durable disease control with existing therapies. The company has in-licensed three clinical-stage product candidates: Tibulizumab (ZB-106), a bispecific antibody targeting IL-17A and BAFF; Crebankitug (ZB-168), an IgG1 monoclonal antibody targeting IL-7R; and Torudokimab (ZB-880), an IgG4 monoclonal antibody targeting IL-33.

Share on Social Networks: